 Avalon GloboCare Corp NASDAQ:AVCO has signed a memorandum of understanding with Lu Daopei Hematology Institute LDHI to co-develop precision companion diagnostics for chimeric antigen receptor CAR-T cell therapies, the company announced. LDHI is a hematology research institute based in Beijing developing precision diagnostics based on personalized genomic, proteomic, transcriptomic and metabolomic platforms. 